- £2.02bn
- £2.24bn
- £672.80m
- 82
- 12
- 95
- 73
REG - Genus - FINAL JURY DECISIONS IN US LITIGATION <Origin Href="QuoteRef">GENS.L</Origin>
AnnouncementREG - Genus - FURTHER DECISIONS IN US LITIGATION <Origin Href="QuoteRef">GENS.L</Origin>
AnnouncementREG - Genus - FIRST DECISIONS IN US ANTI-TRUST LITIGATION <Origin Href="QuoteRef">GENS.L</Origin>
AnnouncementREG - Genus - Block listing Interim Review <Origin Href="QuoteRef">GENS.L</Origin>
AnnouncementREG - Genus - Total Voting Rights <Origin Href="QuoteRef">GENS.L</Origin>
AnnouncementREG - Genus - Signs exclusive licence for tech. to combat BRD <Origin Href="QuoteRef">GENS.L</Origin>
AnnouncementREG - Genus - Adoption of Financial Reporting Standard (FRS) 101 <Origin Href="QuoteRef">GENS.L</Origin>
AnnouncementREG - Genus - Total Voting Rights <Origin Href="QuoteRef">GENS.L</Origin>
AnnouncementREG - Genus - Second Price Monitoring Extn <Origin Href="QuoteRef">GENS.L</Origin>
AnnouncementREG - Genus - Price Monitoring Extension <Origin Href="QuoteRef">GENS.L</Origin>
AnnouncementREG - Genus - Total Voting Rights <Origin Href="QuoteRef">GENS.L</Origin>
AnnouncementREG - Genus - Exclusive Licence for Leading Gene Editing Tech <Origin Href="QuoteRef">GENS.L</Origin>
AnnouncementREG - Genus - Total Voting Rights <Origin Href="QuoteRef">GENS.L</Origin>
AnnouncementREG - Genus - Director/PDMR Shareholding <Origin Href="QuoteRef">GENS.L</Origin>
AnnouncementREG - Genus - Director/PDMR Shareholding <Origin Href="QuoteRef">GENS.L</Origin>
AnnouncementREG - Genus - Director/PDMR Shareholding <Origin Href="QuoteRef">GENS.L</Origin>
AnnouncementREG - Genus - BOARD APPOINTMENT <Origin Href="QuoteRef">GENS.L</Origin>
AnnouncementREG - Genus - Director/PDMR Shareholding <Origin Href="QuoteRef">GENS.L</Origin>
AnnouncementREG - Genus - Director/PDMR Shareholding <Origin Href="QuoteRef">GENS.L</Origin>
Announcement